Global Cancer Supportive Care Medicine Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Cancer Supportive Care Medicine

• 1.1 Definition of Cancer Supportive Care Medicine
• 1.2 Cancer Supportive Care Medicine Segment by Type
  • 1.2.1 Global Cancer Supportive Care Medicine Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Antiemetic Drugs
  • 1.2.3 Erythropoietin-Stimulating Agents
  • 1.2.4 Granulocyte-Stimulating Agents
  • 1.2.5 Analgesics
  • 1.2.6 Others
• 1.3 Cancer Supportive Care Medicine Segment by Applications
  • 1.3.1 Global Cancer Supportive Care Medicine Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Chemotherapy-Induced Anemia
  • 1.3.3 CINV
  • 1.3.4 Bone Metastasis
  • 1.3.5 Cancer Pain
  • 1.3.6 Other
• 1.4 Global Cancer Supportive Care Medicine Overall Market
  • 1.4.1 Global Cancer Supportive Care Medicine Revenue (2014-2025)
  • 1.4.2 Global Cancer Supportive Care Medicine Production (2014-2025)
  • 1.4.3 North America Cancer Supportive Care Medicine Status and Prospect (2014-2025)
  • 1.4.4 Europe Cancer Supportive Care Medicine Status and Prospect (2014-2025)
  • 1.4.5 China Cancer Supportive Care Medicine Status and Prospect (2014-2025)
  • 1.4.6 Japan Cancer Supportive Care Medicine Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Cancer Supportive Care Medicine Status and Prospect (2014-2025)
  • 1.4.8 India Cancer Supportive Care Medicine Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine
• 2.3 Manufacturing Process Analysis of Cancer Supportive Care Medicine
• 2.4 Industry Chain Structure of Cancer Supportive Care Medicine

3 Development and Manufacturing Plants Analysis of Cancer Supportive Care Medicine

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Cancer Supportive Care Medicine Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Cancer Supportive Care Medicine
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Cancer Supportive Care Medicine Production and Capacity Analysis
• 4.2 Cancer Supportive Care Medicine Revenue Analysis
• 4.3 Cancer Supportive Care Medicine Price Analysis
• 4.4 Market Concentration Degree

5 Cancer Supportive Care Medicine Regional Market Analysis

• 5.1 Cancer Supportive Care Medicine Production by Regions
  • 5.1.1 Global Cancer Supportive Care Medicine Production by Regions
  • 5.1.2 Global Cancer Supportive Care Medicine Revenue by Regions
• 5.2 Cancer Supportive Care Medicine Consumption by Regions
• 5.3 North America Cancer Supportive Care Medicine Market Analysis
  • 5.3.1 North America Cancer Supportive Care Medicine Production
  • 5.3.2 North America Cancer Supportive Care Medicine Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Cancer Supportive Care Medicine Import and Export
• 5.4 Europe Cancer Supportive Care Medicine Market Analysis
  • 5.4.1 Europe Cancer Supportive Care Medicine Production
  • 5.4.2 Europe Cancer Supportive Care Medicine Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Cancer Supportive Care Medicine Import and Export
• 5.5 China Cancer Supportive Care Medicine Market Analysis
  • 5.5.1 China Cancer Supportive Care Medicine Production
  • 5.5.2 China Cancer Supportive Care Medicine Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Cancer Supportive Care Medicine Import and Export
• 5.6 Japan Cancer Supportive Care Medicine Market Analysis
  • 5.6.1 Japan Cancer Supportive Care Medicine Production
  • 5.6.2 Japan Cancer Supportive Care Medicine Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Cancer Supportive Care Medicine Import and Export
• 5.7 Southeast Asia Cancer Supportive Care Medicine Market Analysis
  • 5.7.1 Southeast Asia Cancer Supportive Care Medicine Production
  • 5.7.2 Southeast Asia Cancer Supportive Care Medicine Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Cancer Supportive Care Medicine Import and Export
• 5.8 India Cancer Supportive Care Medicine Market Analysis
  • 5.8.1 India Cancer Supportive Care Medicine Production
  • 5.8.2 India Cancer Supportive Care Medicine Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Cancer Supportive Care Medicine Import and Export

6 Cancer Supportive Care Medicine Segment Market Analysis (by Type)

• 6.1 Global Cancer Supportive Care Medicine Production by Type
• 6.2 Global Cancer Supportive Care Medicine Revenue by Type
• 6.3 Cancer Supportive Care Medicine Price by Type

7 Cancer Supportive Care Medicine Segment Market Analysis (by Application)

• 7.1 Global Cancer Supportive Care Medicine Consumption by Application
• 7.2 Global Cancer Supportive Care Medicine Consumption Market Share by Application (2014-2019)

8 Cancer Supportive Care Medicine Major Manufacturers Analysis

• 8.1 Amgen
  • 8.1.1 Amgen Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.1.2 Amgen Product Introduction, Application and Specification
  • 8.1.3 Amgen Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Helsinn Healthcare
  • 8.2.1 Helsinn Healthcare Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.2.2 Helsinn Healthcare Product Introduction, Application and Specification
  • 8.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Johnson &Johnson
  • 8.3.1 Johnson &Johnson Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.3.2 Johnson &Johnson Product Introduction, Application and Specification
  • 8.3.3 Johnson &Johnson Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Merck
  • 8.4.1 Merck Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.4.2 Merck Product Introduction, Application and Specification
  • 8.4.3 Merck Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 F. Hoffmann-La Roche
  • 8.5.1 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.5.2 F. Hoffmann-La Roche Product Introduction, Application and Specification
  • 8.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 GlaxoSmithKline
  • 8.6.1 GlaxoSmithKline Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.6.2 GlaxoSmithKline Product Introduction, Application and Specification
  • 8.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Heron Therapeutics
  • 8.7.1 Heron Therapeutics Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.7.2 Heron Therapeutics Product Introduction, Application and Specification
  • 8.7.3 Heron Therapeutics Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Kyowa Hakko Kirin
  • 8.8.1 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.8.2 Kyowa Hakko Kirin Product Introduction, Application and Specification
  • 8.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Novartis
  • 8.9.1 Novartis Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.9.2 Novartis Product Introduction, Application and Specification
  • 8.9.3 Novartis Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 TESARO
  • 8.10.1 TESARO Cancer Supportive Care Medicine Production Sites and Area Served
  • 8.10.2 TESARO Product Introduction, Application and Specification
  • 8.10.3 TESARO Cancer Supportive Care Medicine Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served
• 8.11 Teva Pharmaceutical Industries

9 Development Trend of Analysis of Cancer Supportive Care Medicine Market

• 9.1 Global Cancer Supportive Care Medicine Market Trend Analysis
  • 9.1.1 Global Cancer Supportive Care Medicine Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Cancer Supportive Care Medicine Regional Market Trend
  • 9.2.1 North America Cancer Supportive Care Medicine Forecast 2019-2025
  • 9.2.2 Europe Cancer Supportive Care Medicine Forecast 2019-2025
  • 9.2.3 China Cancer Supportive Care Medicine Forecast 2019-2025
  • 9.2.4 Japan Cancer Supportive Care Medicine Forecast 2019-2025
  • 9.2.5 Southeast Asia Cancer Supportive Care Medicine Forecast 2019-2025
  • 9.2.6 India Cancer Supportive Care Medicine Forecast 2019-2025
• 9.3 Cancer Supportive Care Medicine Market Trend (Product Type)
• 9.4 Cancer Supportive Care Medicine Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Cancer Supportive Care Medicine Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List